Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.89M
-
Shares change
-
+13.6K
-
Total reported value, excl. options
-
$4.46M
-
Value change
-
+$93.3K
-
Put/Call ratio
-
0.04
-
Number of buys
-
20
-
Number of sells
-
-8
-
Price
-
$2.36
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q4 2022
37 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.89M shares
of 107M outstanding shares and own 1.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (856K shares), BlackRock Inc. (260K shares), GEODE CAPITAL MANAGEMENT, LLC (188K shares), Equitable Holdings, Inc. (113K shares), STATE STREET CORP (71.7K shares), MILLENNIUM MANAGEMENT LLC (61.2K shares), DIMENSIONAL FUND ADVISORS LP (58.6K shares), MORGAN STANLEY (55.6K shares), XTX Topco Ltd (55.4K shares), and NORTHERN TRUST CORP (37.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.